The Thai pharmaceutical industry will soon have to decide on the pricing of its medications and other goods.
The government announced that drug makers will begin a public consultation to determine how much the industry should charge for the drugs they make.
The announcement comes as the country’s pharmaceutical industry struggles to keep up with the rise in drug prices in the past few years.
The prices of some drugs are now double what they were a few years ago.
Thailand’s government said it will make a decision on pricing this year.
The price of some medicines, including some medicines for high blood pressure and heart disease, will be more than double what it was a few months ago.
The Pharmaceutical Council of Thailand said it wants to “reduce prices and increase access” in order to bring the industry “to a level of profitability.”
Some drugs cost more than 10 times as much as they did a few decades ago.
There is currently no official price for most of the drugs in Thailand, and the prices are subject to negotiation.
The drug companies have been under pressure from the government to lower prices and lower costs in order for the industry to stay competitive in a rapidly changing pharmaceutical industry.
Thailand has been grappling with a rise in prescription drug prices since the late 2000s.
It has been the most expensive country in the world for prescription drugs, with a median price of nearly $2,500.
That was more than five times higher than the median price in the United States, which is about $900 per prescription.
The country’s economy is also struggling with high unemployment and a government that is losing control over the pharmaceutical industry, which has been hit hard by the rise of China.